1. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. Issue 5 (May 2020) Authors: João, Esaú C; Morrison, R Leavitt; Shapiro, David E; Chakhtoura, Nahida; Gouvèa, Maria Isabel S; de Lourdes B Teixeira, Maria; Fuller, Trevon L; Mmbaga, Blandina T; Ngocho, James S; Njau, Boniface N; Violari, Avy; Mathiba, Ruth; Essack, Zaakirah; Pilotto, Jose Henrique S; Moreira, Luis Felipe; Ro... Journal: Lancet Issue: Volume 7:Issue 5(2020) Page Start: e322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study. Issue 1 (January 2022) Authors: Bekker, Adrie; Capparelli, Edmund V; Violari, Avy; Cotton, Mark F; Cababasay, Mae; Wang, Jiajia; Mathiba, Ruth; Wiesner, Lubbe; Wiznia, Andrew; Samson, Pearl; Browning, Renee; Moye, Jack; Nakwa, Firdose L; Decloedt, Eric; Rabie, Helena; Mirochnick, Mark; Cressey, Tim R Journal: Lancet Issue: Volume 9:Issue 1(2022) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Issue 9 (September 2022) Authors: Turkova, Anna; Waalewijn, Hylke; Chan, Man K; Bollen, Pauline D J; Bwakura-Dangarembizi, Mutsa F; Kekitiinwa, Adeodata R; Cotton, Mark F; Lugemwa, Abbas; Variava, Ebrahim; Ahimbisibwe, Grace Miriam; Srirompotong, Ussanee; Mumbiro, Vivian; Amuge, Pauline; Zuidewind, Peter; Ali, Shabinah; Kityo, Ci... Journal: Lancet Issue: Volume 9:Issue 9(2022) Page Start: e627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial. Issue 9 (September 2022) Authors: Amuge, Pauline; Lugemwa, Abbas; Wynne, Ben; Mujuru, Hilda A; Violari, Avy; Kityo, Cissy M; Archary, Moherndran; Variava, Ebrahim; White, Ellen; Turner, Rebecca M; Shakeshaft, Clare; Ali, Shabinah; Nathoo, Kusum J; Atwine, Lorna; Liberty, Afaaf; Bbuye, Dickson; Kaudha, Elizabeth; Mngqibisa, Rosie;... Journal: Lancet Issue: Volume 9:Issue 9(2022) Page Start: e638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗